Inhaler use and their carbon footprint in Germany: a 10-year analysis (2013–2022)

BMJ Open Respir Res 2025;12:e003329. doi:10.1136/bmjresp-2025-003329

Interessenskonflikte:

SB is part of the Health for Future movement. MS has received speaker honoraria from AstraZeneca outside of this work. None of the author disclose financial grants or interests related in any way to this study.